NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Exide's Fourth Quarter Results Slightly Exceed Estimates

Motilal Oswal's research report on Exide Industries has revealed that the company's fourth quarter (4QFY26) Profit After Tax (PAT) stood at INR3.1 billion, surpassing the research firm's estimate of INR3 billion. This performance was driven by the healthy double-digit growth experienced in most key segments on a year-over-year (YoY) basis.

However, Exide's revenue growth was modest, with a 9.4% increase mainly attributed to weak exports and a continued decline in the telecom segment. Despite this, the outlook for the lead-acid business remains positive, particularly for the auto segment and the industrial business, excluding the telecom sector. Conversely, concerns regarding the long-term returns from the lithium-ion business persist.

Valuation Assessment

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Exide's stock is currently trading at a price-to-earnings (P/E) ratio of approximately 26.1x and 23.3x for the fiscal years 2027 (FY27E) and 2028 (FY28E) earnings per share (EPS), respectively. This valuation appears to be fairly reasonable. Motilal Oswal has reiterates a Neutral rating for the stock, with a SOTP-based target price (TP) of INR327. The research firm values the core lead-acid business at 15x FY28E EPS, in line with Amara Raja Batteries. Additionally, Exide's value is enhanced by INR59 per share for the electric vehicle (EV) business, based on book value, and INR50 per share for its stake in HDFC Life.

RecommendationMotilal Oswal
RatingNeutral
Target Price (TP)INR327
Valuation MethodologySOTP-based

The overall outlook for Exide remains cautious, with the research firm emphasizing the need for careful consideration of the company's long-term prospects.

Investor Takeaway

Exide Industries is fairly valued at the current price.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.